What causes epistaxis in hereditary hemorrhagic telangiectasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Causes Nosebleeds in HHT

Nosebleeds in HHT are caused by fragile telangiectasias (abnormal dilated blood vessels) in the nasal mucosa that bleed spontaneously or with minimal trauma, driven by underlying VEGF excess and dysregulated angiogenesis from mutations in genes like ENG or ACVRL1. 1

Underlying Pathophysiology

The root cause is genetic mutations that disrupt normal blood vessel development:

  • Mutations in ENG (HHT type 1) or ACVRL1/ALK1 (HHT type 2) account for approximately 85% of cases 2
  • These mutations lead to VEGF (vascular endothelial growth factor) excess 1
  • The VEGF excess supports abnormal growth of telangiectasias—dilated, fragile blood vessels that lack normal capillary beds 1
  • These telangiectasias form direct artery-to-vein connections without the structural integrity of normal vessels 2

Why the Nose Specifically

Nasal telangiectasias are the most common manifestation, occurring in over 90% of adults with HHT 1, 3:

  • The nasal mucosa is particularly vulnerable due to constant exposure to airflow and environmental factors
  • Drying and cracking of the fragile nasal mucosa triggers bleeding from these abnormal vessels 1
  • The telangiectasias appear as large, prominent vascular lesions on endoscopy, particularly in the anterior and posterior nasal fossae 4

Severity Correlates with Lesion Characteristics

The morphology and distribution of nasal telangiectasias directly impacts bleeding severity 4:

  • Large and prominent telangiectasias correlate with higher frequency of epistaxis
  • Greater number of nasal subsites involved correlates with higher intensity of nosebleeds
  • Posterior nasal lesions are particularly problematic

Clinical Impact

Epistaxis in HHT is not trivial bleeding:

  • Can last hours per day 1
  • Causes significant psychosocial morbidity, social isolation, and difficulties with employment and daily activities 1
  • Leads to iron deficiency anemia in nearly half of affected individuals 3
  • May require blood transfusions in severe cases 5

Important Clinical Caveat

While epistaxis is the hallmark symptom, approximately 3% of HHT patients may not develop recurrent epistaxis even by age 60-70, leading to delayed or missed diagnosis 6. These atypical presentations can result in serious complications like cerebral hemorrhage before HHT is recognized, so clinicians should maintain suspicion for HHT even without classic epistaxis when other features (telangiectasias, family history, visceral AVMs) are present.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.